Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer's disease.
about
Extracellular Vesicles in Brain Tumors and Neurodegenerative Diseases.Peripheral Blood Brain-Derived Neurotrophic Factor as a Biomarker of Alzheimer's Disease: Are There Methodological Biases?Moringa Oleifera Alleviates Homocysteine-Induced Alzheimer's Disease-Like Pathology and Cognitive Impairments.Homocysteine-lowering gene therapy rescues signaling pathways in brain of mice with intermediate hyperhomocysteinemia
P2860
Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer's disease.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Combined assessment of DYRK1A, ...... arker for Alzheimer's disease.
@en
type
label
Combined assessment of DYRK1A, ...... arker for Alzheimer's disease.
@en
prefLabel
Combined assessment of DYRK1A, ...... arker for Alzheimer's disease.
@en
P2093
P2860
P50
P356
P1476
Combined assessment of DYRK1A, ...... marker for Alzheimer's disease
@en
P2093
A C Camproux
C Feraudet-Tarisse
J M Delabar
P Alexopoulos
P2860
P2888
P356
10.1038/TP.2017.123
P577
2017-06-20T00:00:00Z